Clinical Trials Directory

Trials / Conditions / Stage IIIC Fallopian Tube Cancer AJCC v7

Stage IIIC Fallopian Tube Cancer AJCC v7

18 registered clinical trials studyying Stage IIIC Fallopian Tube Cancer AJCC v7.

StatusTrialSponsorPhase
CompletedRuxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian,
NCT02713386
NRG OncologyPhase 1 / Phase 2
WithdrawnWeb-Based Coping and Communication Skills Intervention in Improving Psychological Adaptation in Patients With
NCT03902379
Rutgers, The State University of New JerseyN/A
Active Not RecruitingMatched Paired Pharmacodynamics and Feasibility Study of Durvalumab in Combination With Chemotherapy in Frontl
NCT02726997
M.D. Anderson Cancer CenterPhase 1 / Phase 2
CompletedPembrolizumab, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV Ovarian, Primary Peritoneal,
NCT02520154
M.D. Anderson Cancer CenterPhase 2
Active Not RecruitingAdavosertib Before Surgery in Treating Patients With Advanced High Grade Ovarian, Fallopian Tube, or Primary P
NCT02659241
M.D. Anderson Cancer CenterEARLY_Phase 1
CompletedTalazoparib in Determining Genetic Effects on Disease Response in Patients With Advanced Ovarian, Fallopian Tu
NCT02316834
M.D. Anderson Cancer CenterEARLY_Phase 1
CompletedEpacadostat Before Surgery in Treating Patients With Newly Diagnosed Stage III-IV Epithelial Ovarian, Fallopia
NCT02042430
National Cancer Institute (NCI)EARLY_Phase 1
Active Not RecruitingTORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid T
NCT02142803
National Cancer Institute (NCI)Phase 1
Active Not RecruitingSurgery and Chemotherapy With or Without Chemotherapy After Surgery in Treating Patients With Ovarian, Fallopi
NCT01970722
City of Hope Medical CenterPhase 1
UnknownDiet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previo
NCT00719303
Gynecologic Oncology GroupPhase 3
CompletedPropranolol Hydrochloride and Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian
NCT01504126
M.D. Anderson Cancer CenterEARLY_Phase 1
UnknownChemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovar
NCT01366183
Gynecologic Oncology Group—
UnknownQuality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer,
NCT01372787
Gynecologic Oncology Group—
Active Not RecruitingCarboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy i
NCT01081262
National Cancer Institute (NCI)Phase 3
Active Not RecruitingPaclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage
NCT01167712
National Cancer Institute (NCI)Phase 3
CompletedCarboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovar
NCT00989651
National Cancer Institute (NCI)Phase 1
UnknownPaclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Ut
NCT00954174
GOG FoundationPhase 3
UnknownPaclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian E
NCT00108745
GOG FoundationPhase 3